Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4Phase 1 4Phase NA 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 6Recruiting 4Unknown 3Terminated 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Lymphoid 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 45Neoplasms 44Multiple Myeloma 42Stomach Neoplasms 35Neoplasm Metastasis 32Leukemia, Myeloid, Acute 32Ovarian Neoplasms 31Lung Neoplasms 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Pancreatic Neoplasms 26Triple Negative Breast Neoplasms 25Recurrence 25Small Cell Lung Carcinoma 21Brain Neoplasms 21Esophageal Neoplasms 20Colonic Neoplasms 20Uterine Cervical Neoplasms 19Lymphoma, Large B-Cell, Diffuse 17Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

Radiotherapy 3Temozolomide 2Vincristine 1Procarbazine 1Lomustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Oligodendroglioma × Clear all
NCT05303519 2026-03-05

SIGMA

Nuvation Bio Inc.

Phase 3 Recruiting
365 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT05331521 2026-02-03

ImproveCodel

University Hospital Heidelberg

Phase 3 Recruiting
406 enrolled
CNS

Oligodendroglioma

NCT04702581 2026-01-29

POLO

Hospices Civils de Lyon

Phase 3 Recruiting
280 enrolled
CNS

Oligodendroglioma

NCT01649830 2020-05-28

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Sun Yat-sen University

Phase 3 Recruiting
290 enrolled
CNS

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡